About Gregg Sessa
Form D filings for HDL Therapeutics in 2023 list Gregg Sessa as director.
Gregg Sessa first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Gregg Sessa in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Gregg Sessa works with at each company, as listed on that company's latest Form D.
HDL Therapeutics, Inc. · Form D, Jul 10, 2023